3557 results for «259»
3557 results
TAVI cases: the unexpected and the unseen
11 Sep 2025 – From PCR Rio Valves 2025
Explore this session to uncover complex and unexpected challenges encountered during TAVI procedures. Cases include incidental findings such as aortic valve annulus pseudoaneurysm, double coronary artery perforation in severe aortic stenosis, and unique scenarios involving self-expanding valve implantation and transseptal access. Learn strategies for managing bioprosthesis...
Tricuspid TEER intraprocedural guidance
12 Sep 2025 – From PCR Rio Valves 2025
Master the intraprocedural guidance essential for successful Tricuspid Transcatheter Edge-to-Edge Repair (TEER). This session provides comprehensive insights into pre-procedural analysis, gap measurement techniques, and step-by-step intraprocedural monitoring with expert tips and tricks.
Mitral TEER intraprocedural guidance
11 Sep 2025 – From PCR Rio Valves 2025
This session offers a detailed exploration of mitral TEER intraprocedural guidance through case-based learning. It highlights step-by-step techniques, including post-processing and key questions interventionalists face regarding residual regurgitation, clip insertion, and evaluating final procedural outcomes.
Minimalist approach to tricuspid valve therapy
11 Sep 2025 – From PCR Rio Valves 2025
This session highlights the minimalist approach to tricuspid valve therapy with TricValve implantation, a contrast-free, minimally invasive procedure guided by transthoracic echo and minimal fluoroscopy. Clinical evidence shows reduced hospitalisations, improved quality of life, and encouraging mid-term outcomes, including smaller right heart chamber dimensions and reduced...
Transcatheter tricuspid valve replacement - Where are we in Latin America?
12 Sep 2025 – From PCR Rio Valves 2025
Stay abreast of the latest advances in transcatheter tricuspid valve replacement (TTVR) across Latin America. This session highlights orthotopic implant technologies, patient selection criteria, early clinical outcomes, and discusses future perspectives including training, technology access, and regional clinical impact.
Extreme TAVI: bicuspid valves, emergency TAVI, dissections and more
12 Sep 2025 – From PCR Rio Valves 2025
Explore extreme and complex TAVI cases that push procedural limits, including urgent interventions, bicuspid valve sizing, valve-in-valve strategies, and rare complications such as type A dissection and late coronary occlusion. This session shares valuable clinical experiences and lessons from challenging scenarios.
Innovation session: new techniques and devices in Latin America
11 Sep 2025 – From PCR Rio Valves 2025
Join this innovation-focused session highlighting new structural heart devices and techniques emerging from Latin America. Review real-world cases including mechanical valve re-intervention, TMVR, novel mitral TEER devices, and first clinical experiences with a new self-expandable transcatheter aortic valve in small annuli. Gain valuable procedural and clinical...
Tricuspid and mitral: fine tuning diagnosis and results in transcatheter valve management
11 Sep 2025 – From PCR Rio Valves 2025
This session focuses on refining diagnosis and treatment outcomes in transcatheter management of tricuspid and mitral valves. Topics include assessment of pulmonary artery pressure changes post-MitraClip, 3D echocardiographic evaluation of tricuspid regurgitation severity, quantitative improvements in imaging, and insights from single-centre experiences. Additional discussions cover bicaval...
Tricuspid valve - Present and future perspectives: a critical appraisal
12 Sep 2025 – From PCR Rio Valves 2025
Explore the cutting-edge developments and practical insights in tricuspid valve interventions in this comprehensive session. Learn about the current status and patient selection for orthotopic valve implantation, gain expert guidance on intraprocedural monitoring with step-by-step tips, and understand the critical information required for pre, intra, and...
Structural heart: demanding anatomies, difficult situations and unusual strategies
12 Sep 2025 – From PCR Rio Valves 2025
Navigate complex structural heart interventions through this session focusing on challenging anatomies and innovative procedural strategies. Topics include orthotopic tricuspid valve replacement amidst anatomical and physiological complexities, percutaneous closure of Valsalva sinus fistula, extreme TAVI approaches for pure aortic regurgitation, management of mitral paravalvular leaks with...
The complexity of transcatheter tricuspid valve interventions
11 Sep 2025 – From PCR Rio Valves 2025
Understand the complexities of transcatheter tricuspid valve interventions through diverse case studies addressing challenging clinical scenarios. Learn about therapeutic alternatives including TEER with pacemaker leads, imaging challenges with ICE, transcatheter tricuspid valve replacement with Evoque and LuxValve devices, and straightforward options like TricValve. Gain perspective on...
Advanced TAVI: techniques, timing, and problem-solving
12 Sep 2025 – From PCR Rio Valves 2025
Advance your knowledge in TAVI with this session addressing sophisticated techniques, procedural timing, and problem-solving in complex cases. Explore TAVI applications in rare quadricuspid valve anatomy with pure aortic insufficiency, strategic decision-making between TAVI and PCI, and innovative solutions for managing aortic stenosis in patients with...
Management of hostile access for TAVI
11 Sep 2025 – From PCR Rio Valves 2025
Access challenges are among the most critical hurdles in TAVI procedures. This session explores how to identify difficult access routes using pre-procedural CT, and demonstrates practical techniques to safely overcome these obstacles. Through real-life case presentations—including challenging femoral access with a shockwave balloon, carotid access, and...
A journey with Charles Dotter: his contribution to transluminal angioplasty
In this interview, Chiara De Biase and Jean Marco embark on a journey through the history of interventional medicine, focusing on Charles Dotter, the pioneer of transluminal angioplasty, and Andreas Grüntzig.
In this first episode, they discuss Dotter's groundbreaking contributions, including the first interventional transluminal angioplasty in 1964, which revolutionized...
First-in-human evaluation of a novel sirolimus-eluting ultra-high molecular weight APTITUDE bioresorbable scaffold: 9- and 24-month imaging and clinical results of the RENASCENT II trial
18 Jun 2020
The novel sirolimus-eluting ultra-high molecular weight APTITUDE bioreabsorbable vascular scaffold (BRS) displays higher mechanical strength, expansion capabilities and resistance to fracture compared to other BRS technologies. RENASCENT II is a prospective, multicentre first-in-human clinical study evaluating the clinical performance of the APTITUDE BRS in the treatment...
Authors :
Management of mitral regurgitation patients undergoing TMVI screening
13 Jan 2022
This study's results emphasise the strengths and limitations of transcatheter mitral valve implantation (TMVI) as a novel and promising therapy providing predictable elimination of MR in most patients, by S. Ludwig et al.
SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk
07 Nov 2021
Although TAVI is an accepted alternative to surgery in patients with severe aortic stenosis who are at high surgical risk, less is known about long-term comparative outcomes among patients with aortic stenosis who are at intermediate surgical risk. P. Redaelli & M. Pighi review the SURTAVI trial...
Author
Author
